HRSA offers funds to aid care transitions for justice-involved individuals

1811581005

Key Takeaways

On April 10, the U.S. Department of Health and Human Services’ Health Resources and Services Administration (HRSA) announced the availability of $51 million in funding opportunities open to HRSA-funded health centers. HRSA-funded health centers, which serve over 30 million patients, play a crucial role in county healthcare systems emphasizing equity and accessibility in healthcare. This new initiative focuses on supporting individuals leaving incarceration by providing health services during the critical 90 days before release, assisting justice-impacted individuals with their return to the community by expanding access to primary healthcare—including mental health and substance use disorder treatment. 

Impact on counties

County governments operate 2,875 of our nation’s 3,160 local jails, admitting approximately 11 million individuals across the United States each year. Many of these individuals have mental health or substance use issues, with serious mental illnesses being three to four times more prevalent among jail inmates than the general population. America’s local jail population includes an estimated 40 percent of people with a serious chronic health condition, 44 percent with a major mental health illness and 63 percent with a substance use disorder.

Leveraging community health centers to deliver health services to incarcerated individuals for 90 days before their release will benefit both counties and their residents in the following ways: 

  • Individuals impacted by the justice system will experience better continuity of care and improved health outcomes as they reintegrate into the community.
  • Successful reintegration of justice involved individuals into the community will reduce rates of jail recidivism attributable to untreated substance use disorder and mental illness.
  • Improved care continuity for justice involved individuals reduces emergency room and hospital utilization rates for this population, which alleviates associated cost burdens on the county. 

Funding guidelines

  • Health Center Program award recipients are invited to apply for this grant to execute innovative approaches to supporting transitions in care for people leaving incarceration.
  • Funding should be used to implement strategies to address the risk of drug overdose, treatment for mental health and substance use disorder, management of chronic conditions and prevention, identification and treatment of infectious diseases.  
  • Funding can be used to provide case management services addressing social determinants of health.
  • This application is currently open to eligible Health Center Program award recipients. There are expected to be approximately 51 recipients with a maximum individual award of $1,000,000.  

Applications are due through Grants.gov on June 10, and through HRSA Electronic Handbooks on July 2.

Learn more  Apply now

Related News

Image of White-House.jpg
Advocacy

DOJ releases updated list of designated sanctuary jurisdictions

On August 5, the U.S. Department of Justice (DOJ) published an updated list of designated “sanctuary jurisdictions” following the Administration’s Protecting American Communities from Criminal Aliens Executive Order.

583889627
Advocacy

FEMA releases nearly $1 billion in preparedness grants

On August 1, the Federal Emergency Management Agency (FEMA) announced nearly $1 billion in new grant funding to help states, local governments, tribes and territories strengthen disaster preparedness.

Fentanyl
Advocacy

HALT Fentanyl Act signed into law

On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.